Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 18;32(4):296–305. doi: 10.1097/WNR.0000000000001596

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Fig. 4 — Effect of fisetin on SCI-induced alteration in spinal cord histology Spinal cord microscopic image of normal rat (a), sham control rat (b), SCI control rat (c), methylprednisolone (30 mg/kg) treated rat (d), fisetin (20 mg/kg) treated rat (e) and fisetin (40 mg/kg) treated rat (f). Spinal cord sections stained with H&E. Images at 40× are typical and representative of each study group. Data are expressed as mean ± SEM (n = 3), and one-way ANOVA followed by the Kruskal–Wallis test was applied for post hoc analysis. *P < 0.05 as compared to SCI control group, ^#P < 0.05 as compared with sham group, ^&P < 0.05 as compared with normal and ^$P < 0.05 as compared with one another. ANOVA, analysis of variance; H&E, hematoxylin and eosin; SCI, spinal cord injury.